Experience

China Renaissance 华兴资本

• China
• Investment Banking
• 200 - 300 Employee

• 董事

  • Jun 2021 - Present



Henlius | 复宏汉霖

• China
• Biotechnology Research
• 100 - 200 Employee

• 抗体研发副总监/高级总监

  • Apr 2020 - Apr 2021

  Working as the Head of Shanghai R&D MCB (molecular and cellular biology) department, associated Director for antibody development in Henlius. Lead large molecule drug discovery and advance to IND stage for finding new immune oncology (I/O) therapy paths for cancer patients, such as bi-specific antibodies. Mainly focusing on exploring tumor associated antigen (TAA) linked therapeutic path using Cancer Immunology method in solid tumor and hematopoietic malignancy. Coordinating with internal teams (CMC and clinical, etc.), local hospitals, institutes/colleges and CROs for pre-clinical and translational science study. Support BD, PR, and other issues in Henlius. Show less



CStone Pharmaceuticals

• China
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Associate Director

  • Nov 2017 - Apr 2020

  Working as Associated Director for pharmacology in pre-clinical part. Lead small molecule and antibody drug project for finding new immune oncology (I/O) therapy path for cancer patients. Focusing on exploring tumorigenesis, tumor metastasis and therapeutic path using Cancer Immunology method. Majorly working on T cell, B cell, NK cell and myeloid cells in solid tumor and hematopoietic malignancy. Coordinating with internal team, local hospital, institutes/colleges, CRO, CRA and CRC paterners for pre-clinical and translational study. Design in vitro and in vivo study panels, qualify analysis results and communicate with internal and external teams for data processing and analysis. Show less



Johnson & Johnson

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Senior Scientist

  • Apr 2016 - Nov 2017

  Translational medicine research on hematopoietic malignancy. Explored Chinese hematopoietic malignancy patients in a phase-0 study. Related functional in vitro and in vivo assay were performed to support discovery team for new targets and immune-therapies exploration. Major focused on T cells and MDSC function and response to drug in hematopoietic malignancy patients. Translational medicine research on hematopoietic malignancy. Explored Chinese hematopoietic malignancy patients in a phase-0 study. Related functional in vitro and in vivo assay were performed to support discovery team for new targets and immune-therapies exploration. Major focused on T cells and MDSC function and response to drug in hematopoietic malignancy patients.



The National Institutes of Health

• United States
• Biotechnology Research
• 700 & Above Employee

• Visiting Fellow

  • Jul 2011 - Apr 2016

  Working as a Visiting Fellow and focusing on T cell development and function regulation. Try to understand T cell related Immunological disorder and T cell involved cancer therapy using molecular method in mouse model. Working as a Visiting Fellow and focusing on T cell development and function regulation. Try to understand T cell related Immunological disorder and T cell involved cancer therapy using molecular method in mouse model.